genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Biomarkers
FDA Approves Guardant Test as First Pan-Cancer Liquid Biopsy, CDx for…
Big Data
A Unicorn Rivalry Shaping the Future of the Synbio Industry
Gene Therapy
At Orchard, Moving from Pruning to Planting
GEN Edge
Massachusetts Biopharma Industry Weathers COVID-19 Impacts on Jobs, Financing
AAV (Adeno-associated virus)
Quartet of COVID-19 Vaccine Candidates Head toward the Homestretch
News
Drug Discovery
Up-to-$1B KaNDy Acquisition Hits Bayer’s Sweet Spot of Women’s Health
Microscopy
Cytoskeleton Protein’s New Role Magnified by Novel Imaging Method
Autism
Cannabis Use during Pregnancy Linked to Increased Risk of Autism in…
Antisense
Potential Prion Disease Treatment Found in Antisense Therapy
Coronavirus
Fast Tracking Drug Therapies for Viral Infections and Cancer
Insights
All
Trends for 2020
Bioprocessing
Digital Biopharma Operations Need Better PAT and Staff Training
Bioprocessing
Plasmid Manufacturer Scales Up Production Capacity to Serve New Therapeutics
Bioprocessing
Label-Free, Non-Destructive Analytic Technique for Biological Applications
Bioprocessing
Remote Control of CAR T Cells to Enhance Safety
A-Lists
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
April 2020 Vol. 40 No.4
Catching Up to Coronavirus: Top 60 Treatments in Development
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Drug Discovery
Up-to-$1B KaNDy Acquisition Hits Bayer’s Sweet Spot of Women’s Health
Bioprocessing
Digital Biopharma Operations Need Better PAT and Staff Training
Bioprocessing
Plasmid Manufacturer Scales Up Production Capacity to Serve New Therapeutics
Bioprocessing
Label-Free, Non-Destructive Analytic Technique for Biological Applications
Magazine
All
Supplement
August 2020 Vol. 40 No. 8
Fully Automated Luxury Drug Discovery
Point of View
Harnessing the Power of In Vitro Antibody Selection from Libraries
August 2020 Vol. 40 No. 8
CRISPR Startups Give Genome Editing Several New Twists
August 2020 Vol. 40 No. 8
Bioprocessing Warms to Artificial Intelligence
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
GEN Live
Gene Therapy: What’s Up With AAV?
GENcast
Virtual Collaborations Push Pharma Forward During Pandemic
Tutorial
In-Depth GPCR Signaling Characterization for Improved Drug Discovery
New Products
Precoated Plates
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Magazine
April 2020 Vol. 40 No.4
April 2020 Vol. 40 No.4
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
April 2020 Vol. 40 No.4
Artificial Intelligence Is Helping Biotech Get Real
April 2020 Vol. 40 No.4
Cell-Based Immunotherapies Do Battle With Solid Tumors
April 2020 Vol. 40 No.4
Cancer Drug Discovery’s “RASzle-Dazzle”
April 2020 Vol. 40 No.4
Coordinating the Move to Bioprocessing 4.0
April 2020 Vol. 40 No.4
Sequencing’s Stars Urge Exploration of New Dimensions
April 2020 Vol. 40 No.4
As Needs Change, the CRO Industry Adapts
April 2020 Vol. 40 No.4
Making the Most of a CDMO Relationship
April 2020 Vol. 40 No.4
Bioprocessing 4.0 from a Contract Manufacturing Perspective
April 2020 Vol. 40 No.4
AI Brings Precision to Cancer Immunotherapy
April 2020 Vol. 40 No.4
Immunotherapy Gets Up Close and Personal
April 2020 Vol. 40 No.4
Infiltrating Solid Tumor Strongholds
April 2020 Vol. 40 No.4
Microbiome May Join Immunotherapy-Boosting Efforts
April 2020 Vol. 40 No.4
Genetically Edited Cell Lines Enter the Fast Lane
April 2020 Vol. 40 No.4
A New Lease on Life for shRNA
April 2020 Vol. 40 No.4
To Improve Protein Aggregation Assessments, Combine PCT and MMS
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
